Biocompatibility Matrix

Specific medical device safety evaluation programs follow International Organization for Standardization (ISO) 10993 standards and the U.S. Food and Drug Administration (FDA) guidance. NAMSA’s Biocompatibility Matrix is based on ISO 10993-1 Evaluation and Testing within a risk management process 2018 edition, as well as the FDA Guidance released in September 2016. While the matrix has been developed as a guideline for biocompatibility evaluation, it is essential that each device be evaluated based on its own unique characteristics.

You may access the matrix by selecting “Download PDF” on the left.